APA (7th ed.) Citation

M, A., A, A., AF, A., S, F. M., & MA, Y. (2026). Hydroxyurea Bridging Before Frontline TKI Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Critical Appraisal. Oncology, 1. https://doi.org/10.1159/000553465

Chicago Style (17th ed.) Citation

M, Abdulgayoom, Alshurafa A, Al-Mashdali AF, F Mohamed S, and Yassin MA. "Hydroxyurea Bridging Before Frontline TKI Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Critical Appraisal." Oncology 2026: 1. https://doi.org/10.1159/000553465.

MLA (9th ed.) Citation

M, Abdulgayoom, et al. "Hydroxyurea Bridging Before Frontline TKI Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Critical Appraisal." Oncology, 2026, p. 1, https://doi.org/10.1159/000553465.